Open-label, non-controlled, multicenter immunogenicity and safety study of MVA-BN smallpox vaccine in children from birth to less than 12 years of age.
Latest Information Update: 26 May 2014
At a glance
- Drugs Modified vaccinia Ankara (Primary)
- Indications Smallpox
- Focus Therapeutic Use
- Sponsors Bavarian Nordic
- 30 Jul 2013 New trial record